Driehaus Small Cap Growth FundDVSMX
Type
Mutual fund
Peer group
US equity: mid companies
Net assets
$1.1B
Expense ratio
0.93%
1-year return
+39.1%
3 years, a year
+19.2%
5 years, a year
+5.2%
Holdings
127
What it aims to do.
Driehaus Small Cap Growth Fund seeks to maximize capital appreciation.
Top 10 holdings.
| Holding | % of fund |
|---|---|
| Northern Institutional Funds | 2.40% |
| PRAX Praxis Precision Medicines Inc | 2.14% |
| PL Planet Labs Pbc | 2.03% |
| LITE Lumentum Holdings Inc. | 1.80% |
| Crinetics Pharmaceuticals Inc. | 1.71% |
| XENE Xenon Pharmaceuticals Inc | 1.70% |
| CW Curtiss-Wright Corp. | 1.69% |
| FN Fabrinet | 1.55% |
| GH Guardant Health Inc | 1.55% |
| IDCC InterDigital, Inc. | 1.49% |
More on DVSMX.
- DVSMX overview
- DVSMX holdings
- DVSMX risk
- DVSMX costs
- DVSMX money in and out
- DVSMX share classes
- Compare DVSMX with other funds
Returns after fees, from the fund's SEC filings up to Mar 2026. Past returns are not a promise. Not financial advice.